Dr. David O. Kovacich, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (1990)
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,470
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1990Medical school: Indiana University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
IN license 01039429A -
Advanced Heart Failure and Transplant Cardiology Physician
IN license 01039429A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Indiana University Health Indianapolis, IN
- Franciscan Health Indianapolis Indianapolis, IN
- Columbus Regional Hospital Columbus, IN
- Franciscan Health Mooresville Mooresville, IN
- Major Hospital Shelbyville, IN
Medical groups
- Franciscan Physician Network (1,170 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,470
- Services billed
- 2,925
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 747 | 636 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 454 | 449 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 388 | 379 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 189 | 189 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 184 | 184 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 174 | 99 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 153 | 153 |
| Critical care, first 30-74 minutes | 149 | 61 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 148 | 89 |
| Established patient office or other outpatient visit, 40-54 minutes | 65 | 63 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 52 payments worth $9,566 in total to this clinician.
| Amgen Inc. | $8,884 |
|---|---|
| Novartis Pharmaceuticals Corporation | $200 |
| Novo Nordisk Inc | $187 |
| E.r. Squibb & Sons, L.l.c. | $65.32 |
| Scpharmaceuticals Inc. | $58.91 |
| AstraZeneca Pharmaceuticals LP | $51.09 |
| Pfizer Inc. | $36.55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.26 |
| Compensation for services other than consulting (speaking, faculty) | $8,169 |
|---|---|
| Food and Beverage | $1,145 |
| Travel and Lodging | $253 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,800 |
| Amgen Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $701 |
| Amgen Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $701 |
| Amgen Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $701 |
| Amgen Inc. Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $467 |
| Amgen Inc. Mar 4, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to TERRE HAUTE, IN | $130 |
| Amgen Inc. Dec 22, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to Terre Haute, IN | $123 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.